Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease

被引:10
|
作者
Zhu, Haimei [1 ]
Briggs, James M. [1 ]
机构
[1] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA
关键词
molecular dynamics; HCV NS3 protease; NS4A; activation; inhibitor; sampling reliability; catalytic triad; essential dynamics; HEPATITIS-C VIRUS; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; PROTEINASE; SIMULATIONS; DOMAIN;
D O I
10.1002/prot.23064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis C virus (HCV) NS3 protease is the key enzyme for its maturation. Three hypotheses have been advanced in the literature to demonstrate the mechanism of the activation of the HCV NS3 protease. A virus-encoded protein NS4A and substrate are proposed to be involved in the activation of the HCV NS3 protease. However, the three hypotheses are not completely consistent with one another. Multiple molecular dynamics simulations were performed on various NS3 protease systems: free NS3 protease, NS3/4A, NS3/inhibitor, and NS3/4A/inhibitor complexes, to further unravel the mechanism of the activation of the NS3 protease. Simulation results suggest that the binding of NS4A induces a classic serine protease conformation of the catalytic triad of the NS3 protease. NS4A rearranges the secondary structure of both the N-terminus and catalytic site of the NS3 protease, reduces the mobility of the global structure of the NS3 protease, especially the catalytic site, and provides a rigid and tight structure, except for the S1 pocket, for the binding and hydrolysis of substrates. The binding of substrate also contributes to the activation of the NS3 protease by an induced-fit of the classic serine protease catalytic triad. However, the global structure of the NS3 protease is still loose and highly flexible without stable secondary structural elements, such as helix alpha 0 at the N-terminus and helix alpha 1 and beta-sheet E1-F1 at the catalytic site. The structure of the NS3 protease without NS4A is not suitable for the binding and hydrolysis of substrates.
引用
收藏
页码:2428 / 2443
页数:16
相关论文
共 50 条
  • [41] Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease
    Rudd, Michael T.
    McCauley, John A.
    Romano, Joseph J.
    Butcher, John W.
    Bush, Kimberly
    McIntyre, Charles J.
    Nguyen, Kevin T.
    Gilbert, Kevin F.
    Lyle, Terry A.
    Holloway, M. Katharine
    Wan, Bang-Lin
    Vacca, Joseph P.
    Summa, Vincenzo
    Harper, Steven
    Rowley, Michael
    Carroll, Steven S.
    Burlein, Christine
    DiMuzio, Jillian M.
    Gates, Adam
    Graham, Donald J.
    Huang, Qian
    Ludmerer, Steven W.
    McClain, Stephanie
    McHale, Carolyn
    Stahlhut, Mark
    Fandozzi, Christine
    Taylor, Anne
    Trainor, Nicole
    Olsen, David B.
    Liverton, Nigel J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7201 - 7206
  • [42] Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases
    Abdullah, Mohd Amir F.
    McWhirter, Sarah M. M.
    Suo, Zucai
    CELLS, 2023, 12 (03)
  • [43] Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease
    Li, Xianfeng
    Zhang, Yong-Kang
    Liu, Yang
    Zhang, Suoming
    Ding, Charles Z.
    Zhou, Yasheen
    Plattner, Jacob J.
    Baker, Stephen J.
    Liu, Liang
    Bu, Wei
    Kazmierski, Wieslaw M.
    Wright, Lois L.
    Smith, Gary K.
    Jarvest, Richard L.
    Duan, Maosheng
    Ji, Jing-Jing
    Cooper, Joel P.
    Tallant, Matthew D.
    Crosby, Renae M.
    Creech, Katrina
    Ni, Zhi-Jie
    Zou, Wuxin
    Wright, Jon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7493 - 7497
  • [44] Designing and molecular docking of cyclic peptides against HCV NS3 protease
    Masoud, Muhammad Shareef
    Bukhari, Shazia Anwer
    Qasim, Muhammad
    Naqvi, Syed Ali Raza
    Ashfaq, Usman A.
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (05) : 1965 - 1969
  • [45] Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease
    Chen, KX
    Njoroge, FG
    Prongay, A
    Pichardo, J
    Madison, V
    Girilavallabhan, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4475 - 4478
  • [46] Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitors
    Chowdhury, Adnan Y.
    Tavis, John E.
    George, Sarah L.
    VIROLOGY, 2014, 456 : 300 - 309
  • [47] Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
    Ye Yu
    Jing-feng Jing
    Xian-kun Tong
    Pei-lan He
    Yuan-chao Li
    You-hong Hu
    Wei Tang
    Jian-ping Zuo
    Acta Pharmacologica Sinica, 2014, 35 : 1074 - 1081
  • [48] A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
    Isken, Olaf
    Langerwisch, Ulrike
    Jirasko, Vlastimil
    Rehders, Dirk
    Redecke, Lars
    Ramanathan, Harish
    Lindenbach, Brett D.
    Bartenschlager, Ralf
    Tautz, Norbert
    PLOS PATHOGENS, 2015, 11 (03) : 1 - 25
  • [49] Molecular principles behind Boceprevir resistance due to mutations in hepatitis C NS3/4A protease
    Nagpal, Neha
    Goyal, Sukriti
    Wahi, Divya
    Jain, Ritu
    Jamal, Salma
    Singh, Aditi
    Rana, Preeti
    Grover, Abhinav
    GENE, 2015, 570 (01) : 115 - 121
  • [50] Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
    Yu, Ye
    Jing, Jing-feng
    Tong, Xian-kun
    He, Pei-lan
    Li, Yuan-chao
    Hu, You-hong
    Tang, Wei
    Zuo, Jian-ping
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (08) : 1074 - 1081